.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Obtain formulation and manufacturing information
  • Set up watchlists for daily email updates

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Merck
Fuji
Mallinckrodt
Baxter
Novartis
Dow
Colorcon
US Department of Justice
Harvard Business School

Generated: June 22, 2017

DrugPatentWatch Database Preview

DISOPYRAMIDE PHOSPHATE Drug Profile

« Back to Dashboard

What is the patent landscape for Disopyramide Phosphate, and when can generic versions of Disopyramide Phosphate launch?

Disopyramide Phosphate is a drug marketed by Nesher Pharms, Teva, Mylan, Superpharm, Watson Labs, Sun Pharm Inds, Aurolife Pharma Llc, Mayne Pharma, Ivax Sub Teva Pharms, and Interpharm. and is included in nineteen NDAs.

The generic ingredient in DISOPYRAMIDE PHOSPHATE is disopyramide phosphate. There are nineteen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the disopyramide phosphate profile page.

Summary for Tradename: DISOPYRAMIDE PHOSPHATE

Patents:0
Applicants:10
NDAs:19
Suppliers / Packagers: see list5
Bulk Api Vendors: see list20
Clinical Trials: see list786
Patent Applications: see list561
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:DISOPYRAMIDE PHOSPHATE at DailyMed

Pharmacology for Tradename: DISOPYRAMIDE PHOSPHATE

Drug ClassAntiarrhythmic
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Nesher Pharms
DISOPYRAMIDE PHOSPHATE
disopyramide phosphate
CAPSULE, EXTENDED RELEASE;ORAL071200-001Dec 15, 1987DISCNNoNo► Subscribe► Subscribe
Interpharm
DISOPYRAMIDE PHOSPHATE
disopyramide phosphate
CAPSULE;ORAL071190-001Jan 15, 1987DISCNNoNo► Subscribe► Subscribe
Watson Labs
DISOPYRAMIDE PHOSPHATE
disopyramide phosphate
CAPSULE;ORAL070240-001Feb 2, 1986DISCNNoNo► Subscribe► Subscribe
Mylan
DISOPYRAMIDE PHOSPHATE
disopyramide phosphate
CAPSULE;ORAL070138-001Jun 14, 1985DISCNNoNo► Subscribe► Subscribe
Aurolife Pharma Llc
DISOPYRAMIDE PHOSPHATE
disopyramide phosphate
CAPSULE;ORAL070470-001Dec 10, 1985DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
US Army
Daiichi Sankyo
Queensland Health
Federal Trade Commission
QuintilesIMS
Covington
McKesson
Express Scripts
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot